Table 1. Open in new tab Clinical and...

Table 1.

Clinical and Laboratory Data of Patients With MTC Enrolled in the CT Immunoassay Interference Study

Patient ID	Gender	Age, y	RET Mutation	Years Since Thyroidectomy	Disease Status	CT, pg/mL	CT-PEG, pg/mL	Recovery, %
A	F	66	Negative	12	B	261	9	3.4
B	F	40	E761D	4	B	36	0.6	1.7
C	M	16	V804M	4	B	38	2.8	7.4
1	F	22	C634Y	2	B/S	21 754	18 567	85.3
2	F	28	Negative	5	B/S	19 800	18 729	94.6
3	M	48	Negative	9	B/S	14 070	12 985	92.3
4	M	35	Negative	9	B/S	11 795	7928	67.2
5	M	62	Negative	9	B/S	11 271	7642	67.8
6	F	44	S891A	4	B/S	10 087	7644	75.8
7	F	46	C634Y	1	B/S	9193	5414	58.9
8	F	44	Negative	7	B/S	941	848	90.1
9	F	67	Negative	14	B/S	744	593	79.7
10	F	57	S891A	4	B/S	429	438	102.1
11	F	22	C634Y	6	B/S	249	338	135.7
12	M	57	S891A	NP	B/S	114	59	51.7
13	M	41	C634Y	3	B/S	87	78	89.7
14	F	39	Negative	6	B/S	57	49	86.0

Patient ID	Gender	Age, y	RET Mutation	Years Since Thyroidectomy	Disease Status	CT, pg/mL	CT-PEG, pg/mL	Recovery, %
A	F	66	Negative	12	B	261	9	3.4
B	F	40	E761D	4	B	36	0.6	1.7
C	M	16	V804M	4	B	38	2.8	7.4
1	F	22	C634Y	2	B/S	21 754	18 567	85.3
2	F	28	Negative	5	B/S	19 800	18 729	94.6
3	M	48	Negative	9	B/S	14 070	12 985	92.3
4	M	35	Negative	9	B/S	11 795	7928	67.2
5	M	62	Negative	9	B/S	11 271	7642	67.8
6	F	44	S891A	4	B/S	10 087	7644	75.8
7	F	46	C634Y	1	B/S	9193	5414	58.9
8	F	44	Negative	7	B/S	941	848	90.1
9	F	67	Negative	14	B/S	744	593	79.7
10	F	57	S891A	4	B/S	429	438	102.1
11	F	22	C634Y	6	B/S	249	338	135.7
12	M	57	S891A	NP	B/S	114	59	51.7
13	M	41	C634Y	3	B/S	87	78	89.7
14	F	39	Negative	6	B/S	57	49	86.0

Abbreviations: F, female; M, male; NP, not performed; B, presenting only biochemical disease; B/S, presenting biochemical and structural disease. Blood serum from patients A, B, and C was suspected for CT immunofluorometric assay interference. RET mutation indicates identified germ line RET mutation. CT was measured by the in-house assay. CT-PEG and CT were measured after PEG treatment.

This Feature Is Available To Subscribers Only